AI in Medicine News — 2026-10-16 (Fri) Evening News

Overview

Funding and deal activity led in imaging and pathology: Sirona Medical's $40M raise and Agilent's planned acquisition of Proscia for up to $270 million (HIT Consultant, Pulse 2.0). In regulation, SimBioSys received an FDA clearance for TumorSight Risk (PR Newswire). Governance items also appeared, including the MHRA's 2030 strategy, the PHTI framework and a RAPS report on expert views on a regulatory framework for clinical AI models (Digital Health, HIT Consultant, RAPS). In drug discovery, China's export-control moves covering AI and biotech drew attention (South China Morning Post, Geopolitechs).

Diagnostics and imaging

- Sirona Medical secured $40M to scale cloud-native radiology and Cortex AI (HIT Consultant, Ventureburn). The headlines give no performance data. - Agilent will acquire Proscia for up to $270 million to expand AI-enabled digital pathology (Pulse 2.0). This is a deal announcement, not clinical evidence. - AI matched expert doctors at measuring children's coronary arteries on ultrasound (Bioengineer.org). The headline gives no study design, sample size or accuracy figures, so the level of evidence cannot be judged. - A webinar featured imaging leaders discussing how to expand AI automation in clinical practice (Radiology Business).

Clinical decision support

- A Columbia survey found that patients want a doctor's eyes on AI medical advice (Bioengineer.org). This is survey evidence of patient attitudes, not of clinical performance. - Patients expressed frustration at a GP surgery's AI receptionist (BBC). - Suki raised $90 Mn in Series E funding to expand healthcare AI (Digital Health News). 【Generative AI and medical documentation】 No notable developments. 【Hospital operations and care delivery】 - A self-supervised AI reads heart rhythms with "hospital-scale accuracy" using Mamba (Bioengineer.org). The headline does not say which data or validation setting was used. - Ajou University Hospital's real-time AI monitoring system went live (Healthcare Asia Magazine). - E Hospital began operating an AI-equipped 3.0-tesla MRI system (Vietnam.vn). - Nearly 3 in 4 Filipinos turn to AI for mental health support (Manila Bulletin). This is a usage survey result, not an assessment of effectiveness or safety. 【Drug discovery and clinical trials】 None of the headlines state a development stage (preclinical, Phase I and so on). - AI biotech Iambic got $150M in IPO cash for "Molecular Superintelligence" drug R&D (MedCity News). - The clinical trial AI race is shifting from automation to integrated platforms (Korea Biomedical Review). - pharmaphorum published a news watch on AI in drug discovery and development (pharmaphorum). - BioBuzz listed 10 life sciences partnerships that use AI as a lab partner (BioBuzz). - China is mulling new tech export bans covering AI, biotech and solar power (South China Morning Post). China also imposed temporary export registration requirements for AI, biotech and solar technologies and is seeking public comment on proposed export restrictions (Geopolitechs). 【Device approvals and regulation】 - FDA clearance: SimBioSys TumorSight Risk, described in the headline as "the World's First AI-Powered, MRI-Derived Breast Cancer Recurrence Risk Assessment" (PR Newswire, Medical Product Outsourcing). The "first" claim comes from the company's headline. The headlines give no performance figures. - Strategy: the MHRA set out AI regulation plans in its new 2030 strategy (Digital Health). This is a plan, not a binding rule. - Expert opinion: "Experts favor a new regulatory framework for clinical AI models" (RAPS). This is not a regulatory decision. - Not a regulatory action: Perimeter Medical Imaging's AI Claire received a special mention in Time Magazine's Best Inventions of 2026 (Time Magazine).

Safety, errors and bias

- AI executives say the industry can't self-police after early warning shots (CGTN). - PHTI released a framework to scale high-value clinical AI over administrative waste (HIT Consultant). - A new paper urges adoption of green AI in healthcare (News-Medical). - First Choice Health kept NSA claim appeals below 1% with Daffodil Health's AI dispute management solution (Business Wire). This is a vendor-announced administrative result. - Eastwood Bio-Medical's AI-driven Materia Medica plan raises questions about commercial execution (kalkine.ca). - LUMS AI Hub partnered with the Office of AI Punjab to advance AI in healthcare (LUMS). 【Research results (major journals)】 None of the items below is identified as appearing in a major journal. - Harvard Medical School reported what it called the first large-scale study of how doctors use AI in medicine (Harvard Medical School). - BrainChat, an AI-powered texting app, was featured as an image (EurekAlert!). - A Cureus paper appraises AI studies in dental and maxillofacial imaging using a task-routed framework for reporting completeness and risk of bias (Cureus).

Developments in Japan

- WIRED.jp reported that doctors have begun asking themselves what work will remain for them in the AI era (WIRED.jp). - Nikkei xTECH covered the current state of industry-specific AI apps in finance, healthcare and entertainment (Nikkei xTECH). - An AI engineer at Iris reached world No. 1 in the AI competition at the MICCAI international conference for the third year in a row (PR TIMES). This is a competition ranking, not clinical validation. - Fortience launched an AI-native diagnostic service to support manufacturers considering AI use (Cloud Watch). This concerns manufacturing, not medicine.

Statements by key figures

No notable developments.